Fedrigoni group to reorganise and separate into three companies

Third Quarter of 2022 Highlights *Third quarter 2022 (“Q3 2022”) net loss was $23.3 million or a $0.13 loss per share (diluted), compared to net earnings of $30.7 million or $0.16 per share in the second quarter of 2022 (“Q2 2022”). This quarter marked the one-year point for the Company operating its acquired forest- products assets. *Lumber continued to experience price volatility in Q3 2022, with an average selling price of $780/ mfbm compared to $1,255/mfbm in Q2 2022. Steeply rising interest rates and inflation reduced demand for lumber products from the second quarter onward, and remain a concern impacting US housing starts and homebuilders’ confidence. *On September 23, 2022, the Company entered into a credit agreement with a tier-1 Canadian bank for up to $140.0 million consisting of a term loan of $15.0 million and an asset-backed revolving credit facility of up to $125.0 million (collectively, the “Credit Facility”). This refinancing replaced a high yield secured term loan (US$87.3 million outstanding at extinguishment)and a $65.0 million asset-backed loan facility (undrawn at time of extinguishment). *On November 7, 2022, the Company announced the sale of its 203,000 acres of private forest land south of Kapuskasing, Ontario, to a third party for cash proceeds of $49.2 million.

Brazil’s Suzano Papel e Celulos closed a deal to acquire a majority stake in Amazonian paper factory Facepa for 310 million reais ($95 million), the wood pulp and paper maker said on Monday in a securities filing. Suzano said it had agreed to buy 92.84 percent of total shares and 99.99 percent of common shares in the company, which manufactures paper towels, napkins, diapers and tissue in factories in Belem and Fortaleza with total capacity of 50,000 tonnes per year. The price is subject to adjustments, Suzano said in the filing.

Ahlstrom-Munksjö announces the launch of TrustShield™ Biological, a personal protective apparel medical fabric designed to shield against hazardous pathogens. The TrustShield™ product portfolio offers a range of medical fabrics designed to provide superior protection in the operating room, clinical and laboratory environments. TrustShield™ fabrics are laser resistant, protect against chemical permeation, and are highly absorbent. They can be easily converted into medical grade gowns or drapes. TrustShield™ Biological is designed for personal protective apparel applications requiring biological protection to prevent penetration of blood and other hazardous fluids that can spread and cause infections. TrustShield™ Biological is a bi-laminate (two layer) fabric that consists of a polypropylene based nonwoven layer designed for comfort, and polyethylene film layer for protection against biohazards.